Cite
'Artificial Intelligence/Machine Learning Based Bioinformatics Platform For Encephalopathy And Medical Decision Improvement Method' in Patent Application Approval Process (USPTO 20240127949)
MLA
“‘Artificial Intelligence/Machine Learning Based Bioinformatics Platform For Encephalopathy And Medical Decision Improvement Method’ in Patent Application Approval Process (USPTO 20240127949).” Health & Medicine Week, 10 May 2024, p. 675. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.792678838&authtype=sso&custid=ns315887.
APA
“Artificial Intelligence/Machine Learning Based Bioinformatics Platform For Encephalopathy And Medical Decision Improvement Method” in Patent Application Approval Process (USPTO 20240127949). (2024, May 10). Health & Medicine Week, 675.
Chicago
Health & Medicine Week. 2024. “‘Artificial Intelligence/Machine Learning Based Bioinformatics Platform For Encephalopathy And Medical Decision Improvement Method’ in Patent Application Approval Process (USPTO 20240127949),” May 10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.792678838&authtype=sso&custid=ns315887.